Will These Stocks Sustain Their YTD Returns – PME, WEB, NEA?

Will these stocks sustain their YTD returns - PME, WEB, NEA?

Pro Medicus Limited (ASX: PME)

Healthcare Technology company, Pro Medicus Limited has returned a 51.25% year-to-date yield as on 12 April 2019. The stock has witnessed a positive performance change of attractive 122.29% over the past 12 months including 40.98% surge seen in the last three months.

PME last traded at $17.310, up 0.64%, with a price to earnings multiple of 105.850x and a market capitalisation of $1.78 billion as on 12 April 2019.

The robust performance of the stock underlines the company’s solid business model that provides radiology information systems (RIS)  and enterprise imaging software to diagnostic imaging groups, hospitals and other related entities.

For the First half of Fiscal 2019, the company reported after-tax profit of $9.082m, an increase of $5.888 million compared to the same period last year. During the period the Company continued to make substantial inroads into the North American market winning a critical $27.0 million contract with Partners Healthcare, the largest health system in the state of Massachusetts.

Its revenue from contracts with customers for the 6 months of the company increased from $15.886 million to $25.315 million, representing an increase of 59.4%. Besides North America, the Group has witnessed a strong performance in its European business including the extension of the contract with a capital sale of $3.049 million with the German government hospital in November.

Sponsored ad by Kalkine

Webjet Limited (ASX: WEB)

Travel and tourism company, Webjet Limited has recorded a 45.89% increase in its stock price year-to-date including a positive price change of 34.23% in the past three months. WEB last traded at $15.820 with a price to earnings multiple of 38.380 x and a market capitalisation of $2.1 billion as on 12 April 2019.

The company has operations through the Middle East, Europe, Asia Pacific and the Americas, connecting highly fragmented suppliers, hoteliers and travel retailers including travel agents, online travel agents, tour operators, and third party-wholesalers.

Webjet’s Total Transactional Value for 1H FY19 increased by 29%, representing a 2% increase in B2C and a 65% increase in B2B. The increase in the directly contracted B2B inventory and greater cross-sell across B2C ancillary products has resulted in the Group’s revenue margin increasing by 25bps on the previous corresponding period.

Adjusting for the impact of acquisitions, organic growth was 21% despite softness in the bookings due to the hot European summer. EBITDA before acquisition and integration costs increased by 42% and NPAT grew by 37% to $25.2 million in 1H FY19.

Nearmap Ltd (ASX: NEA)

Geospatial map technology provider, Nearmap Limited has achieved as high as 97.39% year-to-date return and the positive price change of 66.39% over the past three months. NEA last traded at $3.230, up 6.95%, on 12 April 2019.

On the back of continuing improvement in US sales, Nearmap annualised contract value rose 42% to $78.3 million in 1H FY2019, compared to the previous corresponding period. Its global customer numbers increased to over 9,300 with group average revenue per subscription increasing to $8,410 during the half-year.

The result demonstrates the favourable impact of the company’s expansion in product, technology and content with continued record US growth and a strengthening market leadership position in Australia.

Nearmap has planned to launch new innovative products in the second half including 3D content visualisation through MapBrowser. It further aims to scale for a global opportunity and become the world’s leading provider of subscription-based location intelligence.


This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Facebook Comments

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report


Please enter your comment!
Please enter your name here